Fintel reports that on March 25, 2025, Stifel initiated coverage of Crinetics Pharmaceuticals (NasdaqGS:CRNX) with a Buy recommendation. Analyst Price Forecast Suggests 114.68% Upside As of March 19, ...
Fintel reports that on March 14, 2025, Stifel upgraded their outlook for Danaher (NYSE:DHR) from Hold to Buy. Analyst Price ...
Finra panel says Stifel was 'required to have heightened supervision' of a broker A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly ...
What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...